MILRINONE Injection 10mg "TAKATA" (ミルリノン注10mg「タカタ」)
Country: Japan
Language: English
Source: すりの適正使用協議会 RAD-AR Council, Japan
Patient Information leaflet
(PIL)
01-01-2016
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Milrinone
Available from:
TAKATA Pharmaceutical Co., Ltd.
INN (International Name):
Milrinone
Pharmaceutical form:
injection
Patient Information leaflet
Drug Information Sheet("Kusuri-no-Shiori")
Injection
Published: 01/2016
The information on this sheet is based on approvals granted by the
Japanese regulatory authority. Approval
details may vary by country. Medicines have adverse reactions (risks)
as well as efficacies (benefits). It is
important to minimize adverse reactions and maximize efficacy. To
obtain a better therapeutic response,
patients should understand their medication and cooperate with the
treatment.
BRAND NAME:
MILRINONE INJECTION 10MG "TAKATA"
ACTIVE INGREDIENT:
Milrinone
DOSAGE FORM:
injection
IMPRINT OR PRINT ON WRAPPING:
EFFECTS OF THIS MEDICINE
This medicine enhances cardiac contractility and dilates blood
vessels.
It is usually used to treat acute heart failure.
THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS
MEDICINE.BE SURE TO TELL YOUR DOCTOR
AND PHARMACIST.
・If you have previously experienced any allergic reactions (itch,
rash, etc.) to any medicines
or foods.
If you have hypertrophic obstructive cardiomyopathy, tachyarrhythmia,
renal dysfunction or
hypotension.
・If you are pregnant or breastfeeding.
・If you are taking any other medicinal products. (Some medicines may
interact to enhance or
diminish medicinal effects. Beware of over-the-counter medicines and
dietary supplements
as well as other prescription medicines.)
DOSING SCHEDULE (HOW TO TAKE THIS MEDICINE)
・
Your dosing schedule prescribed by your doctor is((
to be written by a healthcare
professional
))
・In general, inject intravenously. Subsequently, inject by
intravenous infusion.
・The treatment period with this medicine depends on your response to
the treatment.
PRECAUTIONS WHILE TAKING THIS MEDICINE
POSSIBLE ADVERSE REACTIONS TO THIS MEDICINE
The most commonly reported adverse reactions include tachycardia,
liver dysfunction and
vomiting. If any of these symptoms occur, consult with your doctor or
pharmacist.
THE SYMPTOMS DESCRIBED BELOW ARE RARELY SEEN AS INITIAL SYMPTOMS OF
THE ADVERSE REACTIONS INDICATED
Read the complete document
